CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts.
CB2 is a Gi protein-coupled receptor activated by endo- and phytocannabinoids, thus inhibiting stimulated adenylyl cyclase activity. CB2 is expressed in bone cells and Cb2 null mice show a marked age-related bone loss. CB2-specific agonists both attenuate and rescue ovariectomy-induced bone loss. Activation of CB2 stimulates osteoblast proliferation and bone marrow derived colony-forming units osteoblastic. Here we show that selective and nonselective CB2 agonists are mitogenic in MC3T3 E1 and newborn mouse calvarial osteoblastic cultures. The CB2 mitogenic signaling depends critically on the stimulation of Erk1/2 phosphorylation and de novo synthesis of MAP kinase-activated protein kinase 2 (Mapkapk2) mRNA and protein. Further downstream, CB2 activation enhances CREB transcriptional activity and cyclin D1 mRNA expression. The CB2-induced stimulation of CREB and cyclin D1 is inhibitable by pertussis toxin, the MEK-Erk1/2 inhibitors PD098059 and U0126, and Mapkapk2 siRNA. These data demonstrate that in osteoblasts CB2 targets a Gi protein-cyclin D1 mitogenic axis. Erk1/2 phosphorylation and Mapkapk2 protein synthesis are critical intermediates in this axis.
Ofek
Orr
O
Bone Laboratory, Hebrew University of Jerusalem, Jerusalem, Israel.
Attar-Namdar
Malka
M
Kram
Vardit
V
Dvir-Ginzberg
Mona
M
Mechoulam
Raphael
R
Zimmer
Andreas
A
Frenkel
Baruch
B
Shohami
Esther
E
Bab
Itai
I
D016475:3T3 Cells; D000818:Animals; D002070:Butadienes / Q000494:pharmacology; D019938:Cyclin D1 / Q000378:metabolism*; D005419:Flavonoids / Q000494:pharmacology; D019206:GTP-Binding Protein alpha Subunits, Gi-Go / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D008934:Mitogens / Q000378:metabolism*; D009570:Nitriles / Q000494:pharmacology; D010006:Osteoblasts / Q000201:enzymology* / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D034741:RNA, Small Interfering / Q000378:metabolism; D043885:Receptor, Cannabinoid, CB2 / Q000378:metabolism*
D002070:Butadienes; D005419:Flavonoids; D008934:Mitogens; D009570:Nitriles; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D043885:Receptor, Cannabinoid, CB2; C113580:U 0126; D019938:Cyclin D1; D019206:GTP-Binding Protein alpha Subunits, Gi-Go; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
Nat Med. 2005 Jul;11(7):774-9
15908955
J Neuroendocrinol. 2008 May;20 Suppl 1:10-4
18426493
EMBO J. 1996 Sep 2;15(17):4629-42
8887554
Bone. 2005 Jan;36(1):93-100
15664007
J Biol Chem. 2001 Mar 9;276(10):7586-92
11108712
Curr Opin Cell Biol. 1997 Apr;9(2):180-6
9069255
J Bone Miner Res. 2003 Nov;18(11):2060-8
14606520
J Cell Biol. 1998 Jul 27;142(2):523-35
9679149
J Cell Biol. 2002 Apr 15;157(2):303-14
11956231
EMBO J. 1997 Apr 15;16(8):1921-33
9155018
J Neuroendocrinol. 2008 May;20 Suppl 1:69-74
18426503
Trends Pharmacol Sci. 2007 Apr;28(4):173-9
17350109
J Bone Miner Res. 2002 Aug;17(8):1401-7
12162494
FASEB J. 2010 Mar;24(3):788-98
19884325
J Cell Biochem. 2004 Nov 1;93(4):741-52
15660418
Endocrinology. 2008 Nov;149(11):5619-26
18635663
Bone. 2009 Oct;45(4):716-25
19560570
Curr Opin Cell Biol. 1995 Dec;7(6):798-805
8608010
Br J Pharmacol. 2008 Jan;153(2):347-57
17994109
Am J Physiol. 1997 May;272(5 Pt 1):C1709-16
9176163
J Cell Biochem. 2001;81(4):594-603
11329614
EMBO J. 1995 Dec 1;14(23):5920-30
8846784
Eur J Pharmacol. 2000 May 19;396(2-3):141-9
10822068
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):696-701
16407142
Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12956-61
16126903
Handb Exp Pharmacol. 2005;(168):53-79
16596771
Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14228-33
10588688
Nat Rev Drug Discov. 2008 May;7(5):438-55
18446159
J Cell Biochem. 2003 Feb 15;88(3):446-54
12532321
J Bone Miner Res. 2001 Jun;16(6):1045-55
11393781
Cell. 2008 Nov 28;135(5):825-37
19041748
Mol Pharmacol. 1995 Sep;48(3):443-50
7565624
Structure. 2003 Jun;11(6):611-2
12791249
J Biol Chem. 2001 Jun 15;276(24):21351-8
11292824
Mol Pharmacol. 2006 Sep;70(3):786-92
16772520
Front Biosci. 1998 Aug 01;3:d804-16
9682034
FEBS Lett. 1995 May 8;364(2):229-33
7750577
Cell. 1995 Jan 27;80(2):179-85
7834738
J Biol Chem. 2004 Jul 9;279(28):29121-9
15128746
J Bone Miner Res. 2007 Jul;22(7):951-64
17501623
J Biol Chem. 2005 Nov 11;280(45):37495-502
16150701
Oncogene. 1994 Apr;9(4):1295-304
8134134
Biochem J. 2007 Jan 15;401(2):485-95
16989639
J Biol Chem. 1996 Apr 26;271(17):9902-5
8626625
Cell. 1994 Sep 23;78(6):1027-37
7923353
J Biol Chem. 2002 Mar 1;277(9):7493-500
11741978
Oncogene. 1998 Sep 17;17(11 Reviews):1331-42
9779981
Pain. 2001 Sep;93(3):239-245
11514083